Skip to main content

Table 1 Subgroup analysis of the correlation between the expression levels of glycolysis markers and OS according to the specific glycolysis markers, region, sample, and detection method

From: Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis

Subgroup

HR (95% CI)

Heterogeneity I2 (%), P

Indicators:

MLXIPL

1.88 (1.02, 3.47)

NA

GLUT4

1.44 (0.40, 5.20)

NA

PKM2

1.93 (1.70, 2.18)

I2 = 0.0%, P = 0.704

MAP17

1.64 (1.36, 1.98)

NA

PFKFB3

2.45 (1.09, 5.52)

NA

STMN1

2.57 (1.43, 4.65)

I2 = 49.6%, P = 0.138

PGM1

1.71 (1.11, 2.63)

NA

MCT4

1.64 (1.30, 2.07)

I2 = 0.0%, P = 0.755

GLUT1

1.47 (1.05, 2.05)

I2 = 44.1%, P = 0.181

CDK1

1.99 (0.37, 10.70)

NA

HK-2

2.12 (1.66, 2.71)

I2 = 0.0%, P = 0.604

CA9

2.26 (1.47, 3.47)

I2 = 41.1%, P = 0.165

Homer1

1.66 (0.78, 3.54)

NA

ASCT2

1.76 (1.12, 2.76)

NA

LDHB

0.66 (0.46, 0.93)

NA

TRIM35

0.60 (0.39, 0.92)

NA

PGK-1

3.09 (1.31, 7.29)

NA

GLUT2

1.65 (0.86, 3.20)

I2 = 0.0%, P = 0.347

Region:

China

1.66 (1.43, 1.94)

I2 = 67.4%, P < 0.001

Japan

2.37 (1.44, 3.88)

I2 = 28.1%, P = 0.234

Germany

1.95 (1.34, 2.83)

I2 = 0.0%, P = 0.493

Taiwan

2.70 (1.64, 4.45)

I2 = 21.5%, P = 0.280

South Korea

2.19 (1.14, 4.20)

NA

Hong Kong

1.75 (1.02, 3.00)

NA

US

1.86 (1.23, 2.82)

NA

Sample:

  

Tissue

1.80 (1.57, 2.05)

I2 = 60.3%, P < 0.001

Serum

1.82 (1.29, 2.56)

I2 = 0.0%, P = 0.704

Detection method:

  

IHC

1.80 (1.56, 2.07)

I2 = 63.4%, P < 0.001

qRT-PCR

1.80 (1.30, 2.50)

I2 = 0.0%, P = 0.885

IF

2.45 (1.09, 5.52)

NA

ELISA

1.69 (1.02, 2.81)

NA

  1. MLXIPL MLX interacting protein like, GLUT4 glucose transporter 4, PKM2 pyruvate kinase M2, MAP17 membrane-associated protein 17, PFKFB3 phosphofructokinase-2/fructose-2,6-bisphosphatase 3, STMN1 stathmin 1, PGM1 phosphoglucomutase 1, MCT4 monocarboxylic acid transporter 4, GLUT1 glucose transporter 1, CDK1 cyclin dependent kinase 1, HK-2 hexokinase 2, CA9 carbonic anhydrase IX, ASCT2, alanine-serine-cysteine transporter 2, LDHB lactate dehydrogenase B, TRIM35, tripartite motif-containing 35, PGK-1 phosphoglycerate kinase-1, GLUT2 glucose transporter 2, HR hazard ratio, IHC immunohistochemistry, qRT-PCR quantitative real time polymerase chain reaction, IF immunofluorescence, ELISA enzyme linked immunosorbent assay